Home About Us Corporate Technology Career News Contact Us Feedback
Home

Recent Publicaions from BioCOS(Updated):

1. Expression-based network biology identifies alteration in key regulatory pathways of Type 2 Diabetes and associated risk/complications (PLoS ONE, December 2009 | Volume 4 | Issue 12).

2. An integrated network biology approach identifies transcriptionally altered pathways indicating risk of cardiovascular diseases in Diabetes Type II condition. APBC 2010 (The Eighth Asia Pacific Bioinformatics Conference), Bangalore, India, 18-21 January 2010.).

3. Multiscale Analysis of Mass Spectrometry Proteomics Data - Wavelet Based Statistical Feature Detection.(In National Conference on Proteomic applications: Perspectives in Healthcare (NCPPH) 28th & 29th January 2010 at Karunya University, Tamil Nadu).

4. Significant deregulated pathways in Diabetes type II complications identified through expression based network biology. IC3 2009, CCIS 40, pp. 445 - 453, 2009


BioCOS Life Sciences

R&D company leverages its core strengths in cell & molecular biology, systems level computational methodologies, signal & image processing, statistical and mathematical algorithms in broad areas of biomedical and life sciences.

Its research strengths are in developing various technologies and offer various products for network biology, drug target identification, biomarker & drug discovery and imaging algorithms and solutions for wide range of life sciences areas.

Based on its technologies, BioCOS Life Sciences also offers performance optimized, cost effective and customized solutions to its customers.

------------------------------------------------------------------------------------------
Research Excellence at BioCOS- Read Scientists Perspective

View BioCOS Flyer (pdf)


Copyright © 2008 BioCOS Life Sciences Pvt. Ltd. All Rights Reserved